Paul Dimarco
Urology · Rochester, NYNPI 1417972605
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.4% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by Astellas Pharma US Inc at 24.6% of the total. That places this record below the midpoint for urology clinicians in NY, where the typical reported total is $2,467.
Across 158 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$674
- Johnson & Johnson$603
- Antares Pharma, Inc.$271
- Pfizer$164
- Coloplast$151
- Tolmar Pharmaceuticals, Inc.$139
- plus $743 from 23 others
What the payments were for
- Food & beverage$2,51091%
- Education$2369%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 45 | $674 |
| Johnson & Johnson(2 entities) | 29 | $603 |
| Antares Pharma, Inc. | 13 | $271 |
| Pfizer | 11 | $164 |
| Coloplast | 9 | $151 |
| Tolmar Pharmaceuticals, Inc. | 7 | $139 |
| Clarus Therapeutics Inc. | 5 | $78 |
| Endo Pharmaceuticals Inc. | 3 | $59 |
| Merck | 3 | $58 |
| Therapeuticsmd, Inc. | 3 | $52 |
| Zyla Life Sciences, Inc. | 4 | $49 |
| Medtronic(2 entities) | 2 | $44 |
| Myovant Sciences Inc. | 3 | $38 |
| Dendreon Pharmaceuticals LLC | 2 | $34 |
| Biotissue Holdings Inc. | 2 | $33 |
| Foundation Medicine, Inc. | 2 | $30 |
| Myriad Genetic Laboratories, Inc. | 2 | $28 |
| Procept Biorobotics Corporation | 1 | $28 |
| Amgen | 1 | $27 |
| Blue Earth Diagnostics | 1 | $24 |
| AbbVie | 2 | $23 |
| Travere Therapeutics, Inc. | 1 | $21 |
| Janssen Scientific Affairs, LLC | 1 | $20 |
| 180 Medical, Inc. | 1 | $19 |
| Bayer | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Amniox Medical, Inc. | 1 | $17 |
| Metuchen Pharmaceuticals | 1 | $12 |
| Cook Medical LLC | 1 | $11 |
How this compares
$2,746 in reported general payments places this provider in the 50th percentile of 952 urology providers in New York.
Other urology in Rochester
- Ahmed GhaziRochester$71K
- Peter WalterJamestown$1.9M
- Christopher PieczonkaSyracuse$797K
- Bilal ChughtaiNew York$658K
- Katie MurrayNew York$575K
- Neil BanderNew York$544K
- Robert ValenzuelaNew York$494K
- Jeffrey SpencerCheektowaga$430K
- Kyrollis AttallaNew York$381K
- Benjamin BruckerNew York$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.